Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

MLA

Liu, Maoxi, et al. “Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.” BioMed Research International, Sept. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1155/2022/3839670.

APA

Liu, M., Feng, Y., Zhang, Y., & Liu, H. (2022). Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. BioMed Research International, 1–7. https://doi.org/10.1155/2022/3839670

Chicago

Liu, Maoxi, Yi Feng, Yixun Zhang, and Haiyi Liu. 2022. “Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.” BioMed Research International, September, 1–7. doi:10.1155/2022/3839670.